Costs

For participants of the electronic MEdical Records and GEnomics (eMERGE) Network phase IV study that are found to have high polygenic risk, the medical cost for some of the tests recommended in the Genome Informed Risk Assessment (GIRA) report for asthma, breast cancer, prostate cancer, and type I diabetes mellitus will be covered by study funds.

If you plan to order one of these tests for your patient who is an eMERGE IV study participant at Mayo Clinic in Rochester, Minnesota, contact the study team at RSTKulloLab@mayo.edu or 507-284-5467 to link the order to study funds. For Mayo Clinic clinicians, you can also staff message Jacob Petrzelka and Scott Nigbur in Epic.

If you plan to order one of these tests for your patient who is an eMERGE IV study participant at Mountain Park Hospital Center in Phoenix, Arizona, contact the study coordinators Cynthia Ramirez at cyramirez@mphc-az.org or Georgia Garza at ggarza@mphc-az.org to link the order to study funds.

Tests covered include:

Condition/ Disease	Mayo Clinic Covered Tests/Procedures	MPHC Covered Tests/Procedures
Asthma	One primary care visit for asthma risk assessment and education	One primary care visit for asthma risk assessment and education Asthma specialist referral Spirometry
Atrial Fibrillation	None	Cardiology visit ECG Heart rhythm monitor Echocardiogram
Breast Cancer	One-time mammogram for participants aged 25-39 One-time breast MRI for participants aged ≥ 25	One-time mammogram for participants aged 25-39 years One-time breast MRI for participants aged ≥ 25 years Breast examination by a clinician Breast oncologist consultation
Chronic Kidney Disease	None	Fasting blood glucose for adults HbA1c Serum creatinine eGFR Urinalysis Blood pressure check Nephrologist consultation
Coronary Heart Disease	None	Lipid and Lp(a) levels Carotid ultrasound for participants aged 18-40 years Coronary calcium scan for participants aged ≥40 years
Hyper- cholesterolemia	None	Lipid levels Specialist referral
Obesity	None	Primary care visit for obesity risk Dietician/nutritionist referral Healthy weight program referral
Prostate Cancer	One-time PSA for participants aged 40-49	One-time PSA for participants aged 40-49 years Rectal examination
Type I Diabetes Mellitus	One-time autoantibody test	One-time autoantibody test HbA1c Fasting blood glucose Urinalysis Urinary ketone levels Endocrinology consultation
Type II Diabetes Mellitus	None	Fasting blood glucose in adults HbA1c Medical nutritionist consultation